The standard of traditional Chinese medicine extract of "373-saponins" independently studied in Sichuan entered the 2018 edition of the German Drug Code for the first time, which took a solid step towards the internationalization of traditional Chinese medicine and traditional Chinese medicine standards. This is the reporter recently held in Chengdu, the "full registration of Chinese medicine EU forum" learned.
"Sichuan Chinese medicine extract standards entered the German Drug Code for the first time, which means that the spread of Chinese medicine in Europe has made breakthrough progress. "Gehade·falanzi, chairman of the German Pharmacopoeia Plant Medicine Committee, said.
The reporter learned that "37triol saponins" is a Chinese medicine extract developed by Chengdu Taihe Health Technology Group Co., Ltd. and is used in the production of Sanqi Tongshu capsules, a new Chinese medicine. This species is used to prevent and treat cardio-cerebrovascular diseases. Its pharmacodynamic material is clear, its mechanism of action is clear, and its clinical efficacy is remarkable.
"Chinese medicine and Chinese herbal compound preparations have not obtained legal status in Europe and the United States, but foreign countries have preemptively established international research organizations, which shows their expectations for Chinese medicine. "Yaoxinsheng, an academician of the Chinese Academy of Engineering, believes that the Sichuan Chinese medicine extract standard has entered the" German Drug Code "for the first time as an example. On this basis, the pace of internationalization of Chinese medicine in the future will be gradually accelerated.